The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Man dead, another critical after double stabbing at Brooklyn park as police detain person of interest: NYPD
Trump scores another endorsement win with Louisiana Senate runoff victory
Louisiana Democrats pick rural farmer to challenge GOP in uphill Senate bid
Ketanji Brown Jackson Really Worried Judges Might Actually Apply Second Amendment In Gun Cases
Judge rules Republican with same name as Sen Dan Sullivan can stay on Alaska primary ballot
Taxpayer Dollars May Have Funded Education Of CCP Assets, Report Reveals
Parents of 7-year-old who died weighing 255 pounds charged with murder in suspected neglect case
Jordan Takes Important Step for Freedom of Christians
America Shouldn’t Need a Political Savior to Hold It Together
Mamdani’s suited pool plunge overshadowed by political clash with GOP gubernatorial candidate
Red States Unite Against California Over It’s Alleged Plot To Impose Green Agenda On Nation
New York Might Make Mamdani’s City-Owned Grocery Stores Permanent
NY AG hopeful blasts Letitia James as Medicaid fraud recoveries collapse: ‘She’s not doing the job’
Trump nominates Oklahoma law enforcement veteran Lance Schroyer to lead ICE as permanent director
Two 14-year-olds flee MTA officers, remain missing after vanishing from New Jersey train station
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Man dead, another critical after double stabbing at Brooklyn park as police detain person of interest: NYPD
Trump scores another endorsement win with Louisiana Senate runoff victory
Louisiana Democrats pick rural farmer to challenge GOP in uphill Senate bid
Ketanji Brown Jackson Really Worried Judges Might Actually Apply Second Amendment In Gun Cases
Judge rules Republican with same name as Sen Dan Sullivan can stay on Alaska primary ballot
Taxpayer Dollars May Have Funded Education Of CCP Assets, Report Reveals
Parents of 7-year-old who died weighing 255 pounds charged with murder in suspected neglect case
Jordan Takes Important Step for Freedom of Christians
America Shouldn’t Need a Political Savior to Hold It Together
Mamdani’s suited pool plunge overshadowed by political clash with GOP gubernatorial candidate
Red States Unite Against California Over It’s Alleged Plot To Impose Green Agenda On Nation
New York Might Make Mamdani’s City-Owned Grocery Stores Permanent
NY AG hopeful blasts Letitia James as Medicaid fraud recoveries collapse: ‘She’s not doing the job’
Trump nominates Oklahoma law enforcement veteran Lance Schroyer to lead ICE as permanent director
Two 14-year-olds flee MTA officers, remain missing after vanishing from New Jersey train station
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
